Search research articles
Contact Us
Filters
Showing results (61-70 of 78) with videos related to
Page
of 8
Sort By:
Biorxiv : the Preprint Server for Biology
|
June 5, 2026
Transient ATR inhibition following ionizing radiation enhances immune-mediated antitumor response and survival
Joshua Deppas, Brian F Kiesel, Frank P Vendetti, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 16, 2016
Risk of Severe Toxicity According to Site of Recurrence in Patients Treated With Stereotactic Body Radiation Therapy for Recurrent Head and Neck Cancer
Diane C Ling, John A Vargo, Robert L Ferris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 27, 2025
Randomized Phase II Study of Concurrent Versus Sequential Pembrolizumab in Combination With Chemoradiation in Locally Advanced Head and Neck Cancer
Dan P Zandberg, Lazar Vujanovic, David A Clump, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 25, 2017
Phase Ib Study of Immune Biomarker Modulation with Neoadjuvant Cetuximab and TLR8 Stimulation in Head and Neck Cancer to Overcome Suppressive Myeloid Signals
Gulidanna Shayan, Benjamin A Kansy, Sandra P Gibson, et al.
Translational Oncology
|
August 7, 2010
A Polymorphic Variant of AFAP-110 Enhances cSrc Activity
David A Clump, Jing Jie Yu, Youngjin Cho, et al.
Journal of Neurosurgery
|
May 10, 2024
Preoperative stereotactic radiosurgery for cerebral metastases: safe, effective, and decreases steroid dependency
Arka N Mallela, Uzoma K Iheagwara, David Fogg, et al.
Cancer Research
|
September 15, 2017
PD-1 Status in CD8<sup>+</sup> T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer
Benjamin A Kansy, Fernando Concha-Benavente, Raghvendra M Srivastava, et al.
The Journal of Clinical Investigation
|
June 29, 2018
ATR kinase inhibitor AZD6738 potentiates CD8+ T cell-dependent antitumor activity following radiation
Frank P Vendetti, Pooja Karukonda, David A Clump, et al.
International Journal of Radiation Biology
|
February 20, 2020
Targeting DNA damage response in head and neck cancers through abrogation of cell cycle checkpoints
Jessica M Molkentine, David P Molkentine, Kathleen A Bridges, et al.
Laryngoscope Investigative Otolaryngology
|
June 23, 2022
Definitive local therapy to head and neck squamous cell carcinoma with distant metastasis
Steven Borson, Yongli Shuai, Barton F Branstetter, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 78) with videos related to
Sort By:
Page
of 8
Biorxiv : the Preprint Server for Biology
|
June 5, 2026
Transient ATR inhibition following ionizing radiation enhances immune-mediated antitumor response and survival
Joshua Deppas, Brian F Kiesel, Frank P Vendetti, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 16, 2016
Risk of Severe Toxicity According to Site of Recurrence in Patients Treated With Stereotactic Body Radiation Therapy for Recurrent Head and Neck Cancer
Diane C Ling, John A Vargo, Robert L Ferris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 27, 2025
Randomized Phase II Study of Concurrent Versus Sequential Pembrolizumab in Combination With Chemoradiation in Locally Advanced Head and Neck Cancer
Dan P Zandberg, Lazar Vujanovic, David A Clump, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 25, 2017
Phase Ib Study of Immune Biomarker Modulation with Neoadjuvant Cetuximab and TLR8 Stimulation in Head and Neck Cancer to Overcome Suppressive Myeloid Signals
Gulidanna Shayan, Benjamin A Kansy, Sandra P Gibson, et al.
Translational Oncology
|
August 7, 2010
A Polymorphic Variant of AFAP-110 Enhances cSrc Activity
David A Clump, Jing Jie Yu, Youngjin Cho, et al.
Journal of Neurosurgery
|
May 10, 2024
Preoperative stereotactic radiosurgery for cerebral metastases: safe, effective, and decreases steroid dependency
Arka N Mallela, Uzoma K Iheagwara, David Fogg, et al.
Cancer Research
|
September 15, 2017
PD-1 Status in CD8<sup>+</sup> T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer
Benjamin A Kansy, Fernando Concha-Benavente, Raghvendra M Srivastava, et al.
The Journal of Clinical Investigation
|
June 29, 2018
ATR kinase inhibitor AZD6738 potentiates CD8+ T cell-dependent antitumor activity following radiation
Frank P Vendetti, Pooja Karukonda, David A Clump, et al.
International Journal of Radiation Biology
|
February 20, 2020
Targeting DNA damage response in head and neck cancers through abrogation of cell cycle checkpoints
Jessica M Molkentine, David P Molkentine, Kathleen A Bridges, et al.
Laryngoscope Investigative Otolaryngology
|
June 23, 2022
Definitive local therapy to head and neck squamous cell carcinoma with distant metastasis
Steven Borson, Yongli Shuai, Barton F Branstetter, et al.
Page
of 8